Multi-Centre, Observational Study on Safety of Bevacizumab Biosimilars in Clinical Practice Among Chinese Patients

计划入组 272 人 · 首次发布于 2021 年 8 月 17 日

Effect of Fee on Attendance in Cervical Cancer Screening

计划入组 3,124 人 · 首次发布于 2015 年 3 月 4 日

Biosimilar Versus Urinary Gonadotropins

计划入组 130 人 · 首次发布于 2015 年 7 月 21 日

ACT-451840

C₄₇H₅₄N₆O₃

ACT-077825

ACT-005

Biosimilar Collaborations Ireland Ltd.

Ireland

ACT Biotech, Inc.

United States

Enact Holdings

United States

FDA Launches Public Input Process for BsUFA IV Reauthorization to Shape Biosimilar Regulatory Framework Through 2032

FDA Accepts Biosimilar Application for BAT2506, Proposed Golimumab Alternative

FDA Sets October 2025 Decision Date for Xbrane's Ranibizumab Biosimilar Application